verified SJR 0,582 · Q3 • database Scopus / SJR & Web of Science indexed

United States · John Wiley and Sons Inc

workspace_premium Q3 — Rheumatology lock Subscription

International Journal of Rheumatic Diseases

International Journal of Rheumatic Diseases is a journal indexed in SJR in Rheumatology with an H index of 62. It has a price of 2583 €. It has an SJR impact factor of 0,582 and it has a best quartile of Q3. It has an SJR impact factor of 0,582.

International Journal of Rheumatic Diseases focuses its scope in these topics and keywords: rheumatoid, patients, tumor, methotrexate, therapy, reaction, function, longterm, therapies, spondylitisthe, ...

ISSN: 1756-1841

Publisher: John Wiley and Sons Inc

Category: Rheumatology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,582 Q3

H-index 62

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.583 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,582

H-index

Docs (year)

542

Docs 3y

842

Total refs

11788

Cites 3y

1542

Citable 3y

629

Cites/Doc 2y

1.68

Ref/Doc

21.75

Immediate OA

2583 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Arg972insulin receptor substrate-1 polymorphism and risk and severity of rheumatoid arthritis

Which is worse in psoriasis - skin or joints?

Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study

Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee

Development of the Knee OA Pre-Screening Questionnaire

Cross-cultural adaptation of the Revised Korean version of the Fibromyalgia Impact Questionnaire: its association with physical function and quality of life

Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis

Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis

Clinical characteristics of nonradiographic axial spondyloarthritis in Korea: a comparison with ankylosing spondylitis

Canakinumab efficacy in refractory adult-onset PFAPA syndrome

B cells and rheumatoid factors in autoimmunity

Association of HLA-B*27 with ankylosing spondylitis in Kurdish patients

SHOW MORE ARTICLES

Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis

99Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral gammad T cells and CD4+CD25+Foxp3+Tregs

Are general practitioners well informed about fibromyalgia?

Are daily physical activities risk factors for knee osteoarthritis?

Angiotensin-converting enzyme gene polymorphism in Thai patients with systemic lupus erythematosus

Ambulatory arterial stiffness index and carotid intima-media thickness in hypertensive rheumatoid patients: a comparative cross-sectional study

A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults

A rare combination: chylous polyserositis and autoimmune myelofibrosis as a presentation of systemic lupus erythematosus

A novel self-care biomechanical treatment for obese patients with knee osteoarthritis

A case with rheumatod arthritis and atraumatic odontoid fracture: disappearence of bony landmarks

A case series and review of Poncet's disease, and the utility of current diagnostic criteria

A case of rheumatoid arthritis associated with Hashimoto's thyroiditis and thymoma

FAQs

International Journal of Rheumatic Diseases has an SJR of 0,582 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2583 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for International Journal of Rheumatic Diseases is 31%.

International Journal of Rheumatic Diseases

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of International Journal of Rheumatic Diseases?

What is the APC / publication cost?

What is the acceptance rate?